NYSE
33.74USD
-0.93 (-2.68%)
We have scored 55 news catalysts on Doximity, Inc. (DOCS) over the past 12 months. The biggest single-day move next to one of them came Feb 6, 2026, when DOCS closed −16.8%: “Why Doximity Stock Plummeted Today”. Coverage across the window leans negative (average ticker sentiment −0.31). Most of the impact sits in price momentum and forward growth expectations.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
6B
P/E
—
EPS
—
Beta
1.29
52W range
17.15-64.55
Day range
33.70–35.14
Open
34.85
Prev close
34.67
Volume
1.3M
Avg volume
4M
Dividend
0.00
IPO
2021-06-24
Analysts publish price targets on DOCS, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
6 analyst price targets from $24 to $41
as of 2026-09-23
The market is 19% below the median target — more cautious than the analysts.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Doximity, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for DOCS: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
The reconstruction
The price sits at the 17th percentile of published models, 19% below the median target, meaning the market has heard the bull case for AI and rejected it, choosing instead to price a steep deceleration from recent growth.
What the disagreement turns on
Whether Doximity's AI tools are actually capturing new pharmaceutical budgets and reversing the market-share losses alleged in the lawsuits — and the wired data on unit volumes can only confirm the deceleration the price already assumes, not settle the AI monetization question.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
Computed at $26.57 on 2026-09-23 — the quote has since moved +27%, so read this as a record of what was priced in then, not now.
